Related Experiment Video
Updated: Jul 27, 2025

11:10
Expression, Purification, and Antimicrobial Activity of S100A12
Published on: May 13, 2017
8.4K
The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker.
Fabrizio Michetti1,2,3,4, Maria Elisabetta Clementi5, Rosa Di Liddo6
1Department of Neuroscience, Catholic University of the Sacred Heart, 00168 Rome, Italy.
International Journal of Molecular Sciences
|June 10, 2023
Summary
S100B protein, a biomarker for neural distress, acts as a damage-associated molecular pattern. Elevated S100B levels worsen neurological disease symptoms, suggesting its role in neuroinflammation.
Area of Science:
- Neuroscience
- Biochemistry
- Immunology
Background:
- S100B is a calcium-binding protein primarily found in astrocytes.
- It serves as a biomarker for neural distress and is implicated as a Damage-Associated Molecular Pattern (DAMP) molecule.
- Altered S100B levels correlate with disease progression in various neurological disorders.
Purpose of the Study:
- To explore the role of S100B as a common pathogenic factor in neurological diseases.
- To investigate the link between S100B levels, neuroinflammation, and disease severity.
- To evaluate S100B's potential as a therapeutic target.
Main Methods:
- Review of existing literature on S100B in neurological disorders.
- Analysis of S100B levels and distribution in patient and experimental models.
- Correlation studies between S100B alterations and clinical/toxic parameters.
Main Results:
- S100B levels in nervous tissue are directly related to disease progression.
- In experimental models, S100B overexpression exacerbates symptoms, while inactivation ameliorates them.
- Altered S100B levels correlate with clinical and toxic parameters across diverse neurological conditions.
Conclusions:
- S100B protein is a potential common pathogenic factor in various neurological disorders.
- Its role in neuroinflammation may underlie shared pathological processes.
- Modulating S100B activity could offer a therapeutic strategy for neurological diseases.

